tirzepatide tablets vs shots vs. Semaglutide for Weight Loss Tirzepatide vs. Semaglutide: What You

Dual GIP/GLP-1 agonists now represent the highest-revenue growth segment in the GLP-1 weight loss drug market at 18.4% CAGR , with tirzepatide generating USD 18.3 billion in 2025 revenue through Zepbound and Mounjaro surpassing Eli Lillys entire insulin franchise within two years of commercial launch

[DOI] [PMC free article] [PubMed] [Google Scholar] 4

On the positive side, if a dose causes nausea, you can skip the next day or reduce it immediately

Emdin CA, et al

Diet and nutrition while on BelloBella tirzepatide No medication works in isolation

However, you should always consult your healthcare provider before discontinuing to develop an appropriate monitoring and management plan for the transition period